Search Results 121-130 of 2126 for Erleada
Study PT-112-102, a multicenter, open-label dose-finding and pharmacokinetic study of PT-112 in patients with relapsed or refractory multiple myeloma. This is ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
The purpose of this research study is to evaluate a treatment regimen called IRD which will be given to participants after their stem cell transplant in an ...
The purpose of this study is to to take the usual waste material from the removal of hematoma and apply an array of -Omics approaches (including for example ...
The purpose if this study to combine state of the art cerebral signal processing techniques and localization methods with intracranial electrode recordings to ...
The research of Eduardo E. Benarroch, M.D., is focused on alterations of neurochemically defined neuronal groups in the brainstem and hypothalamus that control ...
To prospectively collect blood and tumor tissue from esophageal cancer patients to identify specific esophageal cancer mutations that can be measured in the ...
This study evaluates the use of carfilzomib, lenalidomide, daratumumab, and dexamethasone in subjects with high-risk smoldering multiple myeloma (SMM). Subjects ...
The study is divided into a Screening Period, a Treatment Period (consisting of a Primary Phase, a Day 169 Disease Response Assessment, and an Extension Phase), ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.